DoW Autism Clinical Trial Award
Defense Health Agency Contracting Activity - DHACA
Free. Verify your email, then we send one reminder only.
- Posted
- May 21, 2026
- Amount
- Program total $3.3M
- Closes
- Oct 22, 2026 (in 44 days)
Similar opportunities open now
- DoW Autism Idea Development AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 44 days
- DoW Autism Career Development AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 44 days
- DoW Arthritis Clinical Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 44 days
- DoW Amyotrophic Lateral Sclerosis Research Program, Pilot Clinical Trial AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 22 days
- DoW Ovarian Cancer, Clinical Trial AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 23 days
Classification and identifiers
- Solicitation number
- HT942526ARPCTA
- Assistance listing (CFDA)
- 12.420
Amount
Program total $3.3M
Who can apply
About this opportunity
Summary: The fiscal year 2026 (FY26) Autism Research Program (ARP) Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of autism. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first-in-human, phase 0) to demonstrate the feasibility or inform the design of more advanced trials through large-scale trials to determine efficacy in relevant patient populations. Distinctive Features: Applications are strongly encouraged to address one of the FY26 ARP Clinical Trial Award Areas of Intere...